Global Medtech Conference 2023 Jazz Pharma's diversified drug portfolio drives revenue growth Zanidatamab shows promise with potential FDA approval in late 2024 See why I rate JAZZ as Hold The Global Opportunity Pennsylvania Fund II LP, also known as the GO PA Fund, has staked an investment in a local company
Medtech Conference 2023 Globallogic Life sciences sector saw a drop in M&A deals in H1 2024, but values increased, with Johnson & Johnson (JNJ) leading the pack in dealmaking activities Read more here The "United States Cardiovascular Surgery Devices Market Outlook to 2033 - Beating Heart Surgery Systems and Perfusion Disposables" report has been added to ResearchAndMarketscom's offering The ENGLISH_Nyxoah to Participate in Upcoming Investor Conferences (https://ml-euglobenewswirecom/Resource/Download/30fb4ed2-f5e3-44ff-8eab-b9b613c3d6d6) Its GLP-1 market, valued at about $17 billion in 2023 according to Clarivate speakers said at the Bio Hong Kong 2024 conference Sept 11, and more than 60 companies have jumped on board since the
Comments are closed.